Drug Profile
Research programme: recombinant platelet derived growth factor therapeutics - Trophogen
Latest Information Update: 12 Sep 2023
Price :
$50
*
At a glance
- Originator Trophogen
- Class Recombinant proteins
- Mechanism of Action Platelet-derived growth factor receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Wounds
Most Recent Events
- 06 Sep 2023 Discontinued - Preclinical for Wounds in USA (unspecified route)
- 28 Mar 2020 No recent reports of development identified for preclinical development in Wounds in USA
- 04 Feb 2016 Preclinical trials in Wounds in USA (unspecified route) before February 2016